Department of Children's Infection, Qilu Children's Hospital of Shandong University, Jinan, China.
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9675-9683. doi: 10.26355/eurrev_202009_23057.
This meta-analysis aims to uncover the therapeutic efficacy of probiotics on acute rotavirus diarrhea (RVD) in children.
Randomized controlled studies reporting therapeutic efficacy of probiotics on acute RVD in children published before 1st June 2019 were searched in PubMed, EMBASE, and Cochrane. The citations in all searched literature were manually examined. Data were extracted from eligible literature for calculating STD Mean Difference (SMD) and its corresponding 95% confidence interval (CI). Subsequently, the association between therapeutic efficacy of probiotics and acute RVD in children was evaluated. Moreover, data were weighted by an inverse variance and analyzed by a fixed or random effect model. Heterogeneity test was applied in the enrolled literature. Sensitivity and publication bias was examined. STATA 12.0 was used for meta-analysis.
A total of 19 independent Randomized Controlled Trials (RCTs) involving 1,624 children with acute RVD were enrolled in this study. Three pieces of literature were excluded through sensitivity and publication bias analyses. Data extracted from eligible literature indicated that probiotics could markedly reduce the occurrence of acute RVD in children (SMD=-0.49, 95% CI=-0.74-0.25). Subgroup analysis conducted based on ethnicity uncovered a poor therapeutic efficacy of probiotics on reducing the occurrence of acute RVD in Asian children (SMD=-0.45, 95% CI=-0.94-0.04), which was markedly significant in Caucasian children (SMD=-0.54, 95% CI=-0.78--0.30). In addition, the subgroup analysis based on the probiotic subtypes found a pronounced efficacy of both Lactobacillus acidophilus (SMD=-0.67, 95% CI=-0.92-0.42) and non-Lactobacillus acidophilus probiotic (SMD=-0.45, 95% CI=-0.77-0.14) on the occurrence of acute RVD in children.
Probiotics could reduce the occurrence of acute RVD in children, especially in Caucasian population. Our findings still needed to be further validated in a multi-center institution with larger sample size and more qualified data.
本荟萃分析旨在揭示益生菌治疗儿童急性轮状病毒腹泻(RVD)的疗效。
检索了截止到 2019 年 6 月 1 日之前发表的关于益生菌治疗儿童急性 RVD 的随机对照研究,检索数据库包括 PubMed、EMBASE 和 Cochrane。手工检查所有检索文献的引文。从合格文献中提取数据以计算标准化均数差(SMD)及其相应的 95%置信区间(CI)。然后,评估益生菌治疗儿童急性 RVD 的疗效。此外,通过逆方差对数据进行加权,并通过固定或随机效应模型进行分析。对纳入文献进行异质性检验。进行敏感性和发表偏倚检验。使用 STATA 12.0 进行荟萃分析。
共纳入 19 项独立的随机对照试验(RCT),共 1624 例急性 RVD 患儿。通过敏感性和发表偏倚分析排除了 3 篇文献。从合格文献中提取的数据表明,益生菌能显著降低儿童急性 RVD 的发生率(SMD=-0.49,95%CI=-0.74-0.25)。基于种族的亚组分析表明,益生菌对降低亚洲儿童急性 RVD 的发生率疗效不佳(SMD=-0.45,95%CI=-0.94-0.04),而对白人儿童则有显著疗效(SMD=-0.54,95%CI=-0.78-0.30)。此外,基于益生菌亚型的亚组分析发现,嗜酸乳杆菌(SMD=-0.67,95%CI=-0.92-0.42)和非嗜酸乳杆菌益生菌(SMD=-0.45,95%CI=-0.77-0.14)对儿童急性 RVD 的发生率均有显著疗效。
益生菌可降低儿童急性 RVD 的发生率,特别是在白人人群中。我们的研究结果仍需要在更大的样本量和更多高质量数据的多中心机构中进一步验证。